bioAffinity Technologies, Inc.'s total assets for Q1 2025 were $5.55M, a decrease of -14.84% from the previous quarter. BIAF total liabilities were $4.11M for the fiscal quarter, a 5.02% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.